BMJ Round Table Shared Decision - Making Practicalities

BMJ Round Table Shared Decision - Making Practicalities

Author: The BMJ August 28, 2013 Duration: 23:31

At BMA house, we convened a group of world experts in shared decision making. Inspired by the Salzburg Global Summit meeting we discussed the background, practical challenges, and how to engage patients with their health

The participants were:

Fiona Godlee , editor in chief, BMJ

Angela Coulter , director of global initiatives, Foundation for Informed Medical Decision Making

Albert Mulley , co-founder, Foundation for Informed Medical Decision Making, and director, Dartmouth Center for Health Care Delivery Science

Glyn Elwyn, research professor with an interest in shared decision making, Cardiff University

Muir Gray , chair of the Information Standard, Department of Health, and co-editor (with Gerd Gigerenzer of the new book Better Doctors, Better Patients, Better Decisions: Envisioning Health Care 2020

Marion Collict, national programme manager, shared decision making, NHS (UK’s National Health System)

Alf Collins , consultant in pain medicine, Taunton and Somerset NHS Foundation Trust, and national clinical lead for Co-Creating Health

Margaret McCartney , writer and GP

Anu Dhir , junior surgical trainee and co-signatory of the Salzburg Statement

Gerd Gigerenzer , director, Center for Adaptive Behaviour and Cognition, Max Planck Institute for Human Behaviour

Lisa Schwartz , professor of medicine, Dartmouth Medical School, author (with Steve Woloshin (see below)) of Know Your Chances available free online.

Steve Woloshin , professor of medicine, Dartmouth Medical School

“e-Patient Dave” deBronkart , co-chair, Society for Participatory Medicine

Tessa Richards , analysis editor, BMJ

Sue Ziebland , research director of the Health Experiences Research Group and a reader in qualitative health research, Department of Primary Health Care, University of Oxford


Produced by The BMJ, this weekly audio series delves into the pivotal research and urgent clinical debates shaping modern medicine. Each episode moves beyond the published page, bringing together the authors, critics, and practitioners directly involved to dissect a new study or a pressing health question. The conversation is rigorous and nuanced, designed for those who appreciate the complexity behind headlines. You’ll hear unscripted discussion about methodology, implications for practice, and the occasional healthy disagreement that drives science forward. This isn't just a summary of the latest findings; it's a critical appraisal in real time, offering listeners a front-row seat to the evolving discourse that defines evidence-based care. The Medicine and Science from The BMJ podcast serves as an essential audio companion for clinicians, academics, and anyone keen to understand the ‘why’ and ‘how’ behind medical news. It transforms the latest evidence from the journal into an accessible, thought-provoking dialogue, ensuring that busy professionals can stay deeply informed. Tune in for a direct, intelligent, and often surprising take on the science that matters most.
Author: Language: English Episodes: 1000

Medicine and Science from The BMJ
Podcast Episodes
Cancer drug trials used for regulatory approval are at risk of bias [not-audio_url] [/not-audio_url]

Duration: 27:09
Around half of trials that supported new cancer drug approvals in Europe between 2014 and 2016 were judged to be at high risk of bias, in a new study. Huseyin Naci,assistant professor of health policy a the London School…
Brexit - Planning for medicine shortages [not-audio_url] [/not-audio_url]

Duration: 32:16
This week we saw the release of the much awaited Yellowhammer documents from the government, documents which outline some of the risks involved with Britain’s sudden departure from the EU. The documents themselves outlin…
Extending the UK’s sugar tax to snacks [not-audio_url] [/not-audio_url]

Duration: 25:02
In the UK, for just over a year, we've been paying the "Soft Drinks Industry Levy" - a tax on sugary beverages intended to reduce our consumption of free sugars. That was based on taxes that had happened in other countri…
The government is lacking detail over Brexit planning [not-audio_url] [/not-audio_url]

Duration: 36:50
Brexit. Who knows what’s going to happen in the next few weeks, months, years - the uncertainty is high. In the face of that, you’d hope that the government was doing all it could to plan for any eventuality - let alone…
Tackling burnout in The Netherlands [not-audio_url] [/not-audio_url]

Duration: 24:20
We heard a few podcasts ago about burnout - what it is, and why it should be thought of as a systems issue. Now a project in the Netherlands is trying to investigate who it is that is particularly at risk of burnout, and…
Talk Evidence - Tramadol, medical harm, and alexa [not-audio_url] [/not-audio_url]

Duration: 41:28
Welcome back to Talk Evidence - where Helen Macdonald and Carl Heneghan take you through what's happening in the world of Evidence. This month we'll be discussing tramadol being prescripted postoperatively, and a new EBM…
Gottfried Hirnschall is optimistic about ending the HIV epidemic [not-audio_url] [/not-audio_url]

Duration: 47:14
In 2001, Gottfried Hirnschall joined the WHO to work on the global response to HIV/AIDs, 18 years later he just retired as the director of WHO’s department for HIV and Hepatitis. The intervening period, almost half the t…